Clinical Trials Browser

Carcinoma, Neuroendocrine × irinotecan sucrosofate × Endocrine × Clear all

NCT03837977 2024-12-30

NET02

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine